{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T06:33:34Z","timestamp":1794551614623,"version":"4.9.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Shenzhen Science and Technology Innovation Commission","doi-asserted-by":"publisher","award":["SGDX20210823103802016"],"award-info":[{"award-number":["SGDX20210823103802016"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","award":["MYRG-CRG2022-00008-ICMS"],"award-info":[{"award-number":["MYRG-CRG2022-00008-ICMS"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004733","name":"Universidade de Macau","doi-asserted-by":"publisher","award":["ICMS\/RTO\/EP160\/2023"],"award-info":[{"award-number":["ICMS\/RTO\/EP160\/2023"]}],"id":[{"id":"10.13039\/501100004733","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["0071\/2024\/RIA1"],"award-info":[{"award-number":["0071\/2024\/RIA1"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006469","name":"Fundo para o Desenvolvimento das Ci\u00eancias e da Tecnologia","doi-asserted-by":"publisher","award":["005\/2023\/SKL"],"award-info":[{"award-number":["005\/2023\/SKL"]}],"id":[{"id":"10.13039\/501100006469","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zhuhai Science and Technology Innovation Bureau"},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32301174"],"award-info":[{"award-number":["32301174"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-024-55072-6","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T12:21:38Z","timestamp":1735561298000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":232,"title":["Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2225-9833","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0610-2556","authenticated-orcid":false,"given":"Kepan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5666-8526","authenticated-orcid":false,"given":"Jinzhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8052-4773","authenticated-orcid":false,"given":"Defang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"55072_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJMoa2035389","volume":"384","author":"R Baden Lindsey","year":"2021","unstructured":"Baden Lindsey, R. et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 384, 403\u2013416 (2021).","journal-title":"N. Engl. J. Med."},{"key":"55072_CR2","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","volume":"383","author":"FP Polack","year":"2020","unstructured":"Polack, F. P. et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med. 383, 2603\u20132615 (2020).","journal-title":"N. Engl. J. Med."},{"key":"55072_CR3","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","volume":"6","author":"X Hou","year":"2021","unstructured":"Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078\u20131094 (2021).","journal-title":"Nat. Rev. Mater."},{"key":"55072_CR4","unstructured":"World Health Organization. COVID-19 vaccine tracker and landscape. https:\/\/www.who.int\/publications\/m\/item\/draft-landscape-of-covid-19-candidate-vaccines (2022)."},{"key":"55072_CR5","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/S0005-2736(00)00343-6","volume":"1510","author":"SC Semple","year":"2001","unstructured":"Semple, S. C. et al. Efficient encapsulation of antisense oligonucleotides in lipid vesicles using ionizable aminolipids: formation of novel small multilamellar vesicle structures. Biochim. Biophys. Acta BBA - Biomembr. 1510, 152\u2013166 (2001).","journal-title":"Biochim. Biophys. Acta BBA - Biomembr."},{"key":"55072_CR6","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/S0006-3495(01)76202-9","volume":"80","author":"N Maurer","year":"2001","unstructured":"Maurer, N. et al. Spontaneous entrapment of polynucleotides upon electrostatic interaction with ethanol-destabilized cationic liposomes. Biophys. J. 80, 2310\u20132326 (2001).","journal-title":"Biophys. J."},{"key":"55072_CR7","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jconrel.2005.06.014","volume":"107","author":"J Heyes","year":"2005","unstructured":"Heyes, J., Palmer, L., Bremner, K. & MacLachlan, I. Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids. J. Control. Rel. 107, 276\u2013287 (2005).","journal-title":"J. Control. Rel."},{"key":"55072_CR8","doi-asserted-by":"publisher","first-page":"8529","DOI":"10.1002\/anie.201203263","volume":"51","author":"M Jayaraman","year":"2012","unstructured":"Jayaraman, M. et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew. Chem. Int. Ed. Engl. 51, 8529\u20138533 (2012).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"55072_CR9","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nbt.1602","volume":"28","author":"SC Semple","year":"2010","unstructured":"Semple, S. C. et al. Rational design of cationic lipids for siRNA delivery. Nat. Biotechnol. 28, 172\u2013176 (2010).","journal-title":"Nat. Biotechnol."},{"key":"55072_CR10","doi-asserted-by":"publisher","first-page":"e139","DOI":"10.1038\/mtna.2013.66","volume":"2","author":"BL Mui","year":"2013","unstructured":"Mui, B. L. et al. Influence of polyethylene glycol lipid desorption rates on pharmacokinetics and pharmacodynamics of siRNA lipid nanoparticles. Mol. Ther. Nucleic Acids 2, e139 (2013).","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"55072_CR11","doi-asserted-by":"publisher","first-page":"12181","DOI":"10.1021\/acs.chemrev.1c00244","volume":"121","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Sun, C., Wang, C., Jankovic, K. E. & Dong, Y. Lipids and lipid derivatives for RNA delivery. Chem. Rev. 121, 12181\u201312277 (2021).","journal-title":"Chem. Rev."},{"key":"55072_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","volume":"15","author":"KJ Hassett","year":"2019","unstructured":"Hassett, K. J. et al. Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines. Mol. Ther. - Nucleic Acids 15, 1\u201311 (2019).","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"55072_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16248-y","volume":"11","author":"L Miao","year":"2020","unstructured":"Miao, L. et al. Synergistic lipid compositions for albumin receptor mediated delivery of mRNA to the liver. Nat. Commun. 11, 2424 (2020).","journal-title":"Nat. Commun."},{"key":"55072_CR14","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.jconrel.2016.05.059","volume":"235","author":"S Chen","year":"2016","unstructured":"Chen, S. et al. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA. J. Control. Rel. 235, 236\u2013244 (2016).","journal-title":"J. Control. Rel."},{"key":"55072_CR15","doi-asserted-by":"publisher","first-page":"2106727","DOI":"10.1002\/adfm.202106727","volume":"32","author":"M Cornebise","year":"2022","unstructured":"Cornebise, M. et al. Discovery of a novel amino lipid that improves lipid nanoparticle performance through specific interactions with mRNA. Adv. Funct. Mater. 32, 2106727 (2022).","journal-title":"Adv. Funct. Mater."},{"key":"55072_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1021\/bc300381s","volume":"24","author":"D Zhi","year":"2013","unstructured":"Zhi, D. et al. The headgroup evolution of cationic lipids for gene delivery. Bioconjug. Chem. 24, 487\u2013519 (2013).","journal-title":"Bioconjug. Chem."},{"key":"55072_CR17","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1021\/acs.accounts.1c00544","volume":"55","author":"Y Eygeris","year":"2022","unstructured":"Eygeris, Y., Gupta, M., Kim, J. & Sahay, G. Chemistry of lipid nanoparticles for RNA delivery. Acc. Chem. Res. 55, 2\u201312 (2022).","journal-title":"Acc. Chem. Res"},{"key":"55072_CR18","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1016\/j.ymthe.2018.03.010","volume":"26","author":"S Sabnis","year":"2018","unstructured":"Sabnis, S. et al. A novel amino lipid series for mRNA Delivery: Improved endosomal escape and sustained pharmacology and safety in non-human primates. Mol. Ther. 26, 1509\u20131519 (2018).","journal-title":"Mol. Ther."},{"key":"55072_CR19","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1038\/s41587-023-01679-x","volume":"41","author":"B Li","year":"2023","unstructured":"Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410\u20131415 (2023).","journal-title":"Nat. Biotechnol."},{"key":"55072_CR20","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/s41587-019-0247-3","volume":"37","author":"L Miao","year":"2019","unstructured":"Miao, L. et al. Delivery of mRNA vaccines with heterocyclic lipids increases anti-tumor efficacy by STING-mediated immune cell activation. Nat. Biotechnol. 37, 1174\u20131185 (2019).","journal-title":"Nat. Biotechnol."},{"key":"55072_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5277","volume":"5","author":"KA Whitehead","year":"2014","unstructured":"Whitehead, K. A. et al. Degradable lipid nanoparticles with predictable in vivo siRNA delivery activity. Nat. Commun. 5, 4277 (2014).","journal-title":"Nat. Commun."},{"key":"55072_CR22","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1021\/acs.jmedchem.7b01698","volume":"61","author":"SM Pant","year":"2018","unstructured":"Pant, S. M. et al. Design, synthesis, and testing of potent, selective hepsin inhibitors via application of an automated closed-loop optimization platform. J. Med. Chem. 61, 4335\u20134347 (2018).","journal-title":"J. Med. Chem."},{"key":"55072_CR23","doi-asserted-by":"publisher","first-page":"1700153","DOI":"10.1002\/minf.201700153","volume":"37","author":"D Merk","year":"2018","unstructured":"Merk, D., Friedrich, L., Grisoni, F. & Schneider, G. De Novo design of bioactive small molecules by artificial intelligence. Mol. Inform. 37, 1700153 (2018).","journal-title":"Mol. Inform."},{"key":"55072_CR24","doi-asserted-by":"publisher","first-page":"113806","DOI":"10.1016\/j.addr.2021.05.016","volume":"175","author":"P Bannigan","year":"2021","unstructured":"Bannigan, P. et al. Machine learning directed drug formulation development. Adv. Drug Deliv. Rev. 175, 113806 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"55072_CR25","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jconrel.2021.08.030","volume":"338","author":"W Wang","year":"2021","unstructured":"Wang, W., Ye, Z., Gao, H. & Ouyang, D. Computational pharmaceutics - A new paradigm of drug delivery. J. Control. Rel. 338, 119\u2013136 (2021).","journal-title":"J. Control. Rel."},{"key":"55072_CR26","doi-asserted-by":"publisher","first-page":"2950","DOI":"10.1016\/j.apsb.2021.11.021","volume":"12","author":"W Wang","year":"2022","unstructured":"Wang, W. et al. Prediction of lipid nanoparticles for mRNA vaccines by the machine learning algorithm. Acta Pharm. Sin. B 12, 2950\u20132962 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"55072_CR27","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1038\/s41563-024-01867-3","volume":"23","author":"B Li","year":"2024","unstructured":"Li, B. et al. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry. Nat. Mater. 23, 1002\u20131008 (2024).","journal-title":"Nat. Mater."},{"key":"55072_CR28","doi-asserted-by":"publisher","first-page":"2939","DOI":"10.1002\/adma.201505822","volume":"28","author":"OS Fenton","year":"2016","unstructured":"Fenton, O. S. et al. Bioinspired alkenyl amino alcohol ionizable lipid materials for highly potent in vivo mRNA delivery. Adv. Mater. 28, 2939\u20132943 (2016).","journal-title":"Adv. Mater."},{"key":"55072_CR29","doi-asserted-by":"publisher","first-page":"1805097","DOI":"10.1002\/smll.201805097","volume":"15","author":"KA Hajj","year":"2019","unstructured":"Hajj, K. A. et al. Branched-tail lipid nanoparticles potently deliver mRNA in vivo due to enhanced ionization at endosomal pH. Small 15, 1805097 (2019).","journal-title":"Small"},{"key":"55072_CR30","doi-asserted-by":"publisher","first-page":"20083","DOI":"10.1002\/anie.202008082","volume":"59","author":"X Zhao","year":"2020","unstructured":"Zhao, X. et al. Imidazole-based synthetic Lipidoids for in vivo mRNA delivery into primary T lymphocytes. Angew. Chem. Int. Ed. Engl. 59, 20083\u201320089 (2020).","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"55072_CR31","doi-asserted-by":"publisher","first-page":"e2020401118","DOI":"10.1073\/pnas.2020401118","volume":"118","author":"M Qiu","year":"2021","unstructured":"Qiu, M. et al. Lipid nanoparticle-mediated codelivery of Cas9 mRNA and single-guide RNA achieves liver-specific in vivo genome editing of Angptl3. Proc. Natl Acad. Sci. 118, e2020401118 (2021).","journal-title":"Proc. Natl Acad. Sci."},{"key":"55072_CR32","doi-asserted-by":"publisher","first-page":"7300","DOI":"10.1021\/acs.nanolett.5b02497","volume":"15","author":"KJ Kauffman","year":"2015","unstructured":"Kauffman, K. J. et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 15, 7300\u20137306 (2015).","journal-title":"Nano Lett."},{"key":"55072_CR33","unstructured":"Heyes, J. et al. Compositions and methods for delivering messenger RNA. WO2015011633Al. (2016)."},{"key":"55072_CR34","unstructured":"Benenato, K. E. & Butcher, W. Compounds and compositions for intracellular delivery of agents. WO2017112865Al. (2017)."},{"key":"55072_CR35","unstructured":"Benenato, K. E. Compounds and compositions for intracellular delivery of therapeutic agents. WO2017049245Al. (2018)."},{"key":"55072_CR36","unstructured":"Benenato, K. E., Cornebise, M. & Hennessy, E. Compounds and compositions for intracellular delivery of therapeutic agents. WO2020061367A1. (2020)."},{"key":"55072_CR37","unstructured":"Du, X. & Ansell, S. M. Lipids and lipid nanoparticle formulations for delivery of nucleic acids. US20160376224Al. (2017)."},{"key":"55072_CR38","unstructured":"Du, X. Lipids for use in lipid nanoparticular formulations. WO2019036028A1. (2019)."},{"key":"55072_CR39","unstructured":"Du, X. & Ansell, S. M. Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids. WO2018200943A1. (2018)."},{"key":"55072_CR40","unstructured":"Ansell, S. & Du, X. Novel Lipids and Lipid Nanoparticle Formulations for Delivery of Nucleic Acids. WO2015199952Al. (2015)."},{"key":"55072_CR41","unstructured":"Ansell, S. M. & Du, X. Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids. WO2017075531A1. (2017)."},{"key":"55072_CR42","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ci100050t","volume":"50","author":"D Rogers","year":"2010","unstructured":"Rogers, D. & Hahn, M. Extended-connectivity fingerprints. J. Chem. Inf. Model. 50, 742\u2013754 (2010).","journal-title":"J. Chem. Inf. Model."},{"key":"55072_CR43","unstructured":"Lundberg, S. M. & Lee, S.-I. A Unified Approach to Interpreting Model Predictions. in Advances in Neural Information Processing Systems vol. 30 (Curran Associates, Inc., 2017)."},{"key":"55072_CR44","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.jconrel.2021.03.043","volume":"333","author":"R Verbeke","year":"2021","unstructured":"Verbeke, R., Lentacker, I., De Smedt, S. C. & Dewitte, H. The dawn of mRNA vaccines: The COVID-19 case. J. Control. Rel. 333, 511\u2013520 (2021).","journal-title":"J. Control. Rel."},{"key":"55072_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-021-02441-2","volume":"4","author":"MJ Carrasco","year":"2021","unstructured":"Carrasco, M. J. et al. Ionization and structural properties of mRNA lipid nanoparticles influence expression in intramuscular and intravascular administration. Commun. Biol. 4, 1\u201315 (2021).","journal-title":"Commun. Biol."},{"key":"55072_CR46","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.jconrel.2020.03.043","volume":"322","author":"Y He","year":"2020","unstructured":"He, Y. et al. Can machine learning predict drug nanocrystals? J. Control. Rel. 322, 274\u2013285 (2020).","journal-title":"J. Control. Rel."},{"key":"55072_CR47","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1007\/s13346-022-01253-z","volume":"13","author":"J Deng","year":"2023","unstructured":"Deng, J. et al. Machine learning in accelerating microsphere formulation development. Drug Deliv. Transl. Res. 13, 966\u2013982 (2023).","journal-title":"Drug Deliv. Transl. Res."},{"key":"55072_CR48","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.apsb.2019.04.004","volume":"9","author":"Q Zhao","year":"2019","unstructured":"Zhao, Q., Ye, Z., Su, Y. & Ouyang, D. Predicting complexation performance between cyclodextrins and guest molecules by integrated machine learning and molecular modeling techniques. Acta Pharm. Sin. B 9, 1241\u20131252 (2019).","journal-title":"Acta Pharm. Sin. B"},{"key":"55072_CR49","doi-asserted-by":"publisher","first-page":"118712","DOI":"10.1016\/j.carbpol.2021.118712","volume":"275","author":"J Li","year":"2022","unstructured":"Li, J., Gao, H., Ye, Z., Deng, J. & Ouyang, D. In silico formulation prediction of drug\/cyclodextrin\/polymer ternary complexes by machine learning and molecular modeling techniques. Carbohydr. Polym. 275, 118712 (2022).","journal-title":"Carbohydr. Polym."},{"key":"55072_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/d41586-018-05867-7","volume":"560","author":"H Ledford","year":"2018","unstructured":"Ledford, H. Gene-silencing technology gets first drug approval after 20-year wait. Nature 560, 291\u2013292 (2018).","journal-title":"Nature"},{"key":"55072_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35343-w","volume":"14","author":"P Bannigan","year":"2023","unstructured":"Bannigan, P. et al. Machine learning models to accelerate the design of polymeric long-acting injectables. Nat. Commun. 14, 35 (2023).","journal-title":"Nat. Commun."},{"key":"55072_CR52","doi-asserted-by":"publisher","first-page":"6948","DOI":"10.1021\/ja301621z","volume":"134","author":"D Chen","year":"2012","unstructured":"Chen, D. et al. Rapid discovery of Potent siRNA-containing lipid nanoparticles enabled by controlled microfluidic formulation. J. Am. Chem. Soc. 134, 6948\u20136951 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"55072_CR53","doi-asserted-by":"publisher","first-page":"1864","DOI":"10.1073\/pnas.0910603106","volume":"107","author":"KT Love","year":"2010","unstructured":"Love, K. T. et al. Lipid-like materials for low-dose, in vivo gene silencing. Proc. Natl Acad. Sci. 107, 1864\u20131869 (2010).","journal-title":"Proc. Natl Acad. Sci."},{"key":"55072_CR54","doi-asserted-by":"publisher","unstructured":"Xu, Y. et al. AGILE Platform: A Deep Learning-Powered Approach to Accelerate LNP Development for mRNA Delivery. https:\/\/doi.org\/10.1101\/2023.06.01.543345 (2023)","DOI":"10.1101\/2023.06.01.543345"},{"key":"55072_CR55","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1039\/C3FD00124E","volume":"169","author":"D Rozmanov","year":"2014","unstructured":"Rozmanov, D., Baoukina, S. & Peter Tieleman, D. Density based visualization for molecular simulation. Faraday Discuss. 169, 225\u2013243 (2014).","journal-title":"Faraday Discuss."},{"key":"55072_CR56","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1021\/acs.jpcb.2c07671","volume":"127","author":"M Palonc\u00fdov\u00e1","year":"2023","unstructured":"Palonc\u00fdov\u00e1, M. et al. Atomistic insights into organization of RNA-loaded lipid nanoparticles. J. Phys. Chem. B 127, 1158\u20131166 (2023).","journal-title":"J. Phys. Chem. B"},{"key":"55072_CR57","doi-asserted-by":"publisher","first-page":"6993","DOI":"10.1039\/D0SM00736F","volume":"16","author":"AN Rissanou","year":"2020","unstructured":"Rissanou, A. N., Ouranidis, A. & Karatasos, K. Complexation of single stranded RNA with an ionizable lipid: an all-atom molecular dynamics simulation study. Soft Matter 16, 6993\u20137005 (2020).","journal-title":"Soft Matter"},{"key":"55072_CR58","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrd4278","volume":"13","author":"U Sahin","year":"2014","unstructured":"Sahin, U., Karik\u00f3, K. & T\u00fcreci, \u00d6. mRNA-based therapeutics-developing a new class of drugs. Nat. Rev. Drug Discov. 13, 759\u2013780 (2014).","journal-title":"Nat. Rev. Drug Discov."},{"key":"55072_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.omtn.2024.102175","volume":"35","author":"H Parhiz","year":"2024","unstructured":"Parhiz, H. et al. Physiologically based modeling of LNP-mediated delivery of mRNA in the vascular system. Mol. Ther. - Nucleic Acids 35, 1\u201311 (2024).","journal-title":"Mol. Ther. - Nucleic Acids"},{"key":"55072_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/psp.2013.41","volume":"2","author":"HM Jones","year":"2013","unstructured":"Jones, H. M. & Rowland-Yeo, K. Basic concepts in physiologically based pharmacokinetic modeling in drug discovery and development. CPT Pharmacomet. Syst. Pharmacol. 2, 1\u201312 (2013).","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"55072_CR61","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s11095-022-03333-8","volume":"39","author":"JY Jeon","year":"2022","unstructured":"Jeon, J. Y., Ayyar, V. S. & Mitra, A. Pharmacokinetic and pharmacodynamic modeling of siRNA therapeutics \u2013 a minireview. Pharm. Res. 39, 1749\u20131759 (2022).","journal-title":"Pharm. Res."},{"key":"55072_CR62","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/psp4.12301","volume":"7","author":"JF Apgar","year":"2018","unstructured":"Apgar, J. F. et al. Quantitative systems pharmacology model of hUGT1A1-modRNA encoding for the UGT1A1 enzyme to treat Crigler-Najjar Syndrome Type 1. CPT Pharmacomet. Syst. Pharmacol. 7, 404\u2013412 (2018).","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"55072_CR63","doi-asserted-by":"publisher","first-page":"4591","DOI":"10.1016\/j.apsb.2024.06.011","volume":"14","author":"W Wang","year":"2024","unstructured":"Wang, W., Deng, S., Lin, J. & Ouyang, D. Modeling on in vivo disposition and cellular transportation of RNA lipid nanoparticles via quantum mechanics\/physiologically-based pharmacokinetic approaches. Acta Pharm. Sin. B 14, 4591\u20134607 (2024).","journal-title":"Acta Pharm. Sin. B"},{"key":"55072_CR64","doi-asserted-by":"publisher","first-page":"e1010254","DOI":"10.1371\/journal.pcbi.1010254","volume":"18","author":"A Ruiz-Martinez","year":"2022","unstructured":"Ruiz-Martinez, A. et al. Simulations of tumor growth and response to immunotherapy by coupling a spatial agent-based model with a whole-patient quantitative systems pharmacology model. PLOS Comput. Biol. 18, e1010254 (2022).","journal-title":"PLOS Comput. Biol."},{"key":"55072_CR65","doi-asserted-by":"crossref","unstructured":"Bansal, L. et al. Mathematical modeling of complement pathway dynamics for target validation and selection of drug modalities for complement therapies. Front. Pharmacol. 13, 1\u201320 (2022).","DOI":"10.3389\/fphar.2022.855743"},{"key":"55072_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12275-6","volume":"10","author":"M Maugeri","year":"2019","unstructured":"Maugeri, M. et al. Linkage between endosomal escape of LNP-mRNA and loading into EVs for transport to other cells. Nat. Commun. 10, 4333 (2019).","journal-title":"Nat. Commun."},{"key":"55072_CR67","doi-asserted-by":"publisher","first-page":"103042","DOI":"10.1016\/j.copbio.2023.103042","volume":"85","author":"MY Mata Corral","year":"2024","unstructured":"Mata Corral, M. Y., Alvarez, D. E. & Poon, W. Quantifying nanoparticle delivery: challenges, tools, and advances. Curr. Opin. Biotechnol. 85, 103042 (2024).","journal-title":"Curr. Opin. Biotechnol."},{"key":"55072_CR68","doi-asserted-by":"publisher","first-page":"120586","DOI":"10.1016\/j.ijpharm.2021.120586","volume":"601","author":"L Schoenmaker","year":"2021","unstructured":"Schoenmaker, L. et al. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability. Int. J. Pharm. 601, 120586 (2021).","journal-title":"Int. J. Pharm."},{"key":"55072_CR69","doi-asserted-by":"publisher","first-page":"15085","DOI":"10.1021\/jacs.4c00451","volume":"146","author":"W Dong","year":"2024","unstructured":"Dong, W. et al. Multicomponent synthesis of imidazole-based ionizable lipids for highly efficient and spleen-selective messenger RNA delivery. J. Am. Chem. Soc. 146, 15085\u201315095 (2024).","journal-title":"J. Am. Chem. Soc."},{"key":"55072_CR70","doi-asserted-by":"publisher","unstructured":"Wang, W. Dataset for artificial intelligence-driven rational design of ionizable lipids for mRNA delivery. figshare. https:\/\/doi.org\/10.6084\/m9.figshare.26379541.v1 (2024)","DOI":"10.6084\/m9.figshare.26379541.v1"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55072-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55072-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55072-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T02:02:00Z","timestamp":1735610520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-55072-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["55072"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-55072-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"7 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10804"}}